256 related articles for article (PubMed ID: 32336751)
1. Trends in cervical cancer incidence in sub-Saharan Africa.
Jedy-Agba E; Joko WY; Liu B; Buziba NG; Borok M; Korir A; Masamba L; Manraj SS; Finesse A; Wabinga H; Somdyala N; Parkin DM
Br J Cancer; 2020 Jul; 123(1):148-154. PubMed ID: 32336751
[TBL] [Abstract][Full Text] [Related]
2. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
[TBL] [Abstract][Full Text] [Related]
3. Trends in the incidence of ovarian cancer in sub-Saharan Africa.
Gizaw M; Parkin DM; Stöter O; Korir A; Kamate B; Liu B; Bojang L; N'Da G; Manraj SS; Bukirwa P; Chokunonga E; Chingonzoh T; Peko JF; Finesse A; Somdyala N; Ladipo A; Kantelhardt EJ
Int J Cancer; 2023 Apr; 152(7):1328-1336. PubMed ID: 36274630
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
Ndiaye C; Alemany L; Ndiaye N; Kamaté B; Diop Y; Odida M; Banjo K; Tous S; Klaustermeier JE; Clavero O; Castellsagué X; Bosch FX; Trottier H; de Sanjosé S
Trop Med Int Health; 2012 Dec; 17(12):1432-40. PubMed ID: 23107344
[TBL] [Abstract][Full Text] [Related]
5. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
Lekoane KMB; Kuupiel D; Mashamba-Thompson TP; Ginindza TG
BMC Cancer; 2019 Jun; 19(1):563. PubMed ID: 31185951
[TBL] [Abstract][Full Text] [Related]
6. Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.
Mboumba Bouassa RS; Prazuck T; Lethu T; Jenabian MA; Meye JF; Bélec L
Expert Rev Anti Infect Ther; 2017 Jun; 15(6):613-627. PubMed ID: 28440679
[TBL] [Abstract][Full Text] [Related]
8. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract][Full Text] [Related]
9. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
10. The evolving epidemic of breast cancer in sub-Saharan Africa: Results from the African Cancer Registry Network.
Joko-Fru WY; Jedy-Agba E; Korir A; Ogunbiyi O; Dzamalala CP; Chokunonga E; Wabinga H; Manraj S; Finesse A; Somdyala N; Liu B; McGale P; Jemal A; Bray F; Parkin DM
Int J Cancer; 2020 Oct; 147(8):2131-2141. PubMed ID: 32306390
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus.
Mboumba Bouassa RS; Prazuck T; Lethu T; Meye JF; Bélec L
Med Sante Trop; 2017 Feb; 27(1):16-22. PubMed ID: 28406406
[TBL] [Abstract][Full Text] [Related]
13. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
14. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.
Ogembo RK; Gona PN; Seymour AJ; Park HS; Bain PA; Maranda L; Ogembo JG
PLoS One; 2015; 10(4):e0122488. PubMed ID: 25875167
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry study.
Gizaw M; Parkin DM; Stöter O; Bukirwa P; Seife E; Chesumbai G; Korir A; Liu B; Manraj SS; Nda G; Somdyala NIM; Kantelhardt EJ
Int J Cancer; 2024 Jun; 154(11):1911-1919. PubMed ID: 38339849
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
Egli-Gany D; Spaar Zographos A; Diebold J; Masserey Spicher V; Frey Tirri B; Heusser R; Dillner J; Petignat P; Sahli R; Low N;
BMC Cancer; 2019 Jan; 19(1):111. PubMed ID: 30700274
[TBL] [Abstract][Full Text] [Related]
18. Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.
Nygård M; Hansen BT; Dillner J; Munk C; Oddsson K; Tryggvadottir L; Hortlund M; Liaw KL; Dasbach EJ; Kjær SK
PLoS One; 2014; 9(2):e88323. PubMed ID: 24505474
[TBL] [Abstract][Full Text] [Related]
19. Biopsychosocial risk factors and knowledge of cervical cancer among young women: A case study from Kenya to inform HPV prevention in Sub-Saharan Africa.
Ngune I; Kalembo F; Loessl B; Kivuti-Bitok LW
PLoS One; 2020; 15(8):e0237745. PubMed ID: 32817627
[TBL] [Abstract][Full Text] [Related]
20. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]